Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrzej Pilc

Showing results (41-50 of 153) with videos related to

Pageof 16
Sort By:
Archives of Medical Science : AMS|November 28, 2012
Sipuleucel-T immunotherapy for castration-resistant prostate cancer. A systematic review and meta-analysisPaweł Kawalec, Anna Paszulewicz, Przemysław Holko, et al.
Plos One|May 6, 2015
A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union's PerspectivesPetronille Bogaert, Tomasz Bochenek, Anna Prokop, et al.
Expert Opinion on Emerging Drugs|October 11, 2023
Potential use of psilocybin drugs in the treatment of depressionKatarzyna Śladowska, Paweł Kawalec, Tomasz Brzostek, et al.
Pharmacology, Biochemistry, and Behavior|July 16, 2002
Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in miceAleksandra Kłodzinska, Maria Bijak, Krzysztof Tokarski, et al.
Archives of Medical Science : AMS|November 26, 2013
Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysisPaweł Kawalec, Alicja Mikrut, Natalia Wiśniewska, et al.
Plos One|October 12, 2013
Nevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trialsPaweł Kawalec, Joanna Kryst, Alicja Mikrut, et al.
Pharmacological Reports : PR|November 6, 2023
Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapiesBarbara Chruścicka-Smaga, Agata Machaczka, Bernadeta Szewczyk, et al.
Biochemical Pharmacology|January 1, 2008
Mood disorders: regulation by metabotropic glutamate receptorsAndrzej Pilc, Shigeyuki Chaki, Gabriel Nowak, et al.
Pharmacological Reports : PR|January 16, 2007
Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABAA signalingKatarzyna Stachowicz, Ewa Chojnacka-Wójcik, Kinga Kłak, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|August 27, 2014
[The role of the cytostatic drugs unit in rationalization of hospital drugs management--the case study and the analysis of drug utilization]Sandra Zuziak, Roman Topór-Madry, Andrzej Pilc, et al.
Pageof 16

Showing results (41-50 of 153) with videos related to

Sort By:
Pageof 16
Archives of Medical Science : AMS|November 28, 2012
Sipuleucel-T immunotherapy for castration-resistant prostate cancer. A systematic review and meta-analysisPaweł Kawalec, Anna Paszulewicz, Przemysław Holko, et al.
Plos One|May 6, 2015
A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union's PerspectivesPetronille Bogaert, Tomasz Bochenek, Anna Prokop, et al.
Expert Opinion on Emerging Drugs|October 11, 2023
Potential use of psilocybin drugs in the treatment of depressionKatarzyna Śladowska, Paweł Kawalec, Tomasz Brzostek, et al.
Pharmacology, Biochemistry, and Behavior|July 16, 2002
Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in miceAleksandra Kłodzinska, Maria Bijak, Krzysztof Tokarski, et al.
Archives of Medical Science : AMS|November 26, 2013
Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysisPaweł Kawalec, Alicja Mikrut, Natalia Wiśniewska, et al.
Plos One|October 12, 2013
Nevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trialsPaweł Kawalec, Joanna Kryst, Alicja Mikrut, et al.
Pharmacological Reports : PR|November 6, 2023
Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapiesBarbara Chruścicka-Smaga, Agata Machaczka, Bernadeta Szewczyk, et al.
Biochemical Pharmacology|January 1, 2008
Mood disorders: regulation by metabotropic glutamate receptorsAndrzej Pilc, Shigeyuki Chaki, Gabriel Nowak, et al.
Pharmacological Reports : PR|January 16, 2007
Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABAA signalingKatarzyna Stachowicz, Ewa Chojnacka-Wójcik, Kinga Kłak, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|August 27, 2014
[The role of the cytostatic drugs unit in rationalization of hospital drugs management--the case study and the analysis of drug utilization]Sandra Zuziak, Roman Topór-Madry, Andrzej Pilc, et al.
Pageof 16